Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients.
Anthony Joseph DixonAthanassios KyrgidisHoward K SteinmanJohn B DixonMichael J SladdenClaus GarbeAimillios LallasChristopher B ZacharyUlrike LeiterHarvey Ronald SmithAlexander NirenbergChristos C ZouboulisCaterina LongoGiuseppe ArgenzianoZoi ApallaCatalin PopescuThrasyvoulos TzellosStuart AndersonLena NanzLloyd CleaverJ Meirion ThomasPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
is likely more appropriate. BAUSSS provides a more accurate melanoma-specific mortality risk assessment for patients without burdening them with added surgery, hospitalization, costs or morbidity risk.
Keyphrases
- sentinel lymph node
- risk assessment
- end stage renal disease
- cardiovascular events
- newly diagnosed
- ejection fraction
- chronic kidney disease
- minimally invasive
- lymph node
- early stage
- risk factors
- prognostic factors
- peritoneal dialysis
- neoadjuvant chemotherapy
- heavy metals
- type diabetes
- coronary artery bypass
- high resolution
- cardiovascular disease
- mass spectrometry
- percutaneous coronary intervention
- fine needle aspiration